These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Management of recurrent herpes simplex using levamisole].
    Author: Luderschmidt C, Wolff HH.
    Journal: Hautarzt; 1979 Jan; 30(1):21-4. PubMed ID: 422356.
    Abstract:
    The therapeutic effect of levamisole was tested in a double blind and open clinical study in 30 patients with recurrent labial and genital herpes simplex. The frequency, the duration and the painfulness of the herpes eruptions were improved significantly under levamisole treatment. Agranulocytosis is an important adverse reaction which restricts the practical use of the substance. The increase of phagocytosis of granulocytes and macrophages and the normalization of defective cell mediated immune reactions are the supposed mechanisms of levamisole action.
    [Abstract] [Full Text] [Related] [New Search]